 PHILADELPHIA, Sept. 17, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. Nasdaq: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today announced it has granted inducement awards to eight newly hired employees under an inducement plan adopted by its board of directors. 